← Open Payments lookup

BRITNEY SKILLMAN: Open Payments

NPI 1003489261 · YAKIMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$501 in 18 payments from 6 companies in 2025. Trend: 2023 $176 · 2024 $149 · 2025 $501

Food & beverage: $501
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.8$189
E.R. Squibb & Sons, L.L.C.1$103
Otsuka America Pharmaceutical, Inc.4$78
Teva Pharmaceuticals USA, Inc.2$60
Alkermes, Inc.2$44
Janssen Pharmaceuticals, Inc1$28

Products named: INGREZZA, COBENFY, UZEDY, ARISTADA, ABILIFY ASIMTUFII, INVEGA SUSTENNA, ABILIFY MAINTENA, REXULTI.

Industry payments across WA — which companies pay providers there.